LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
11.43
+0.72 (6.72%)
At close: Jul 1, 2026, 4:00 PM EDT
11.55
+0.12 (1.05%)
Pre-market: Jul 2, 2026, 8:29 AM EDT
LifeStance Health Group Revenue
LifeStance Health Group had revenue of $403.48M in the quarter ending March 31, 2026, with 21.17% growth. This brings the company's revenue in the last twelve months to $1.49B, up 16.46% year-over-year. In the year 2025, LifeStance Health Group had annual revenue of $1.42B with 13.85% growth.
Revenue (ttm)
$1.49B
Revenue Growth
+16.46%
P/S Ratio
2.97
Revenue / Employee
$179,038
Employees
8,349
Market Cap
4.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.42B | 173.32M | 13.85% |
| Dec 31, 2024 | 1.25B | 195.30M | 18.50% |
| Dec 31, 2023 | 1.06B | 196.13M | 22.82% |
| Dec 31, 2022 | 859.54M | 192.03M | 28.77% |
| Dec 31, 2021 | 667.51M | 401.96M | 151.36% |
| Dec 31, 2020 | 265.56M | 53.04M | 24.96% |
| Dec 31, 2019 | 212.52M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Option Care Health | 5.67B |
| Select Medical Holdings | 5.52B |
| PACS Group | 5.43B |
| Astrana Health | 3.53B |
| Acadia Healthcare Company | 3.37B |
| Surgery Partners | 3.34B |
| Brookdale Senior Living | 3.00B |
| Chemed | 2.54B |
LFST News
- 27 days ago - LifeStance initiated with a Neutral at Goldman Sachs - TheFly
- 27 days ago - LifeStance Health Group Transcript: 46th Annual William Blair Growth Stock Conference - Transcripts
- 6 weeks ago - LifeStance Health Group Slides: Investor presentation - Filings
- 7 weeks ago - LifeStance price target raised to $9 from $8 at JPMorgan - TheFly
- 7 weeks ago - LifeStance Health Group Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - LifeStance price target raised to $12 from $11 at BTIG - TheFly
- 7 weeks ago - LifeStance price target raised to $11 from $10 at Canaccord - TheFly
- 7 weeks ago - LifeStance Health Group Announces Pricing of Secondary Public Offering - GlobeNewsWire